Patron Partners LLC bought a new position in Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,413 shares of the conglomerate’s stock, valued at approximately $460,000.
A number of other institutional investors have also recently bought and sold shares of DHR. BlackRock Inc. acquired a new position in shares of Danaher in the 2nd quarter valued at $10,492,520,000. Norges Bank acquired a new stake in shares of Danaher during the 4th quarter valued at about $2,177,106,000. Generation Investment Management LLP bought a new stake in Danaher in the second quarter valued at about $1,287,949,000. Flossbach Von Storch SE bought a new stake in Danaher in the second quarter valued at about $747,260,000. Finally, Bank of New York Mellon Corp acquired a new position in Danaher in the second quarter worth about $712,875,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Price Performance
Shares of Danaher stock opened at $219.42 on Friday. The stock has a market capitalization of $154.25 billion, a price-to-earnings ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78. The firm’s 50-day moving average price is $195.80 and its two-hundred day moving average price is $192.61. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.
Analyst Ratings Changes
A number of equities research analysts have weighed in on DHR shares. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Stifel Nicolaus cut their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Wells Fargo & Company decreased their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Finally, Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.
Read Our Latest Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
